• (+)-fenchol and (-)-isopinocampheol derivatives targeting the entry process of filoviruses
• <em>Myotis</em> bat STING attenuates aging-related inflammation in female mice
• "If I die for touching him, let me die": a rapid ethnographic assessment of cultural practices and Ebola transmission in high-risk border regions of Tanzania
• A broadly-neutralizing antibody against Ebolavirus glycoprotein that potentiates the breadth and neutralization potency of other antibodies
• A comprehensive analysis of non-pharmaceutical interventions and vaccination on Ebolavirus disease outbreak: Stochastic modeling approach
• A novel multi-epitope peptide vaccine targeting immunogenic antigens of Ebola and monkeypox viruses with potential of immune responses provocation in silico
• A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus
• A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus
• Adolescent girls' perceptions of the COVID-19 infodemic in Sierra Leone: a qualitative study in urban, peri-urban and rural Sierra Leone
• Advances in Nucleic Acid Assays for Infectious Disease: The Role of Microfluidic Technology
• Afucosylated anti-EBOV antibody MIL77-3 engages sGP to elicit NK cytotoxicity
• An ancillary care policy in a vaccine trial conducted in a resource-constrained setting: evaluation and policy recommendations
• An update on nonhuman primate usage for drug and vaccine evaluation against filoviruses
• Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement
• AP3B1 facilitates PDIA3/ERP57 function to regulate rabies virus glycoprotein selective degradation and viral entry
• Aptamer and Aptasensor Technology for Diagnosis of Infectious Diseases: A Mini Review
• Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system
• Bat humoral immunity and its role in viral pathogenesis, transmission, and zoonosis
• Building a Biocontainment Unit: Infrastructure and organizational experiences of the 13 regional biocontainment units in the United States
• Building Clinical Care Capacity for Patients With Special Pathogens in Advance of the Next Outbreak
• Can global health security frameworks measure One Health implementation in West Africa?A mixed-methods study
• Chikungunya virus release is reduced by TIM-1 receptors through binding of envelope phosphatidylserine
• Comparison of Routes of Administration, Frequency, and Duration of Favipiravir Treatment in Mouse and Guinea Pig Models of Ebola Virus Disease
• Computational Analysis of the Accumulation of Mutations in Therapeutically Important RNA Viral Proteins During Pandemics with Special Emphasis on SARS-CoV-2
• Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination
• Continuous Community Engagement Is Needed to Improve Adherence to Ebola Response Activities and Survivorship During Ebola Outbreaks
• Correction to: Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells
• Correction To: Ebola Virus Disease Outbreaks: Lessons Learned From Past and Facing Future Challenges
• Current Progress in the Science of Novel Adjuvant Nano-Vaccine-Induced Protective Immune Responses
• Delayed treatment of cynomolgus macaques with a FVM04/CA45 monoclonal antibody cocktail provides complete protection against lethal Sudan virus infection
• Demographic Factors Associated with Presenting for Eye Evaluation in the Partnership for Research on Vaccines and Infectious Diseases in Liberia III Natural History Study of Ebola Virus Disease
• Dysglycaemia in Ebola virus disease: a retrospective analysis from the 2018 to 2020 outbreak
• Ebola virus circulation in a non-epidemic Guinean rural area: a mixed-method approach to assessing endemicity
• Ebola virus disease mathematical models and epidemiological parameters: a systematic review
• Effectiveness of psychological first aid in infectious disease pandemics: An overview of systematic reviews
• Effectiveness of rVSV-ZEBOV vaccination during the 2018-20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative study
• Enmity then empathy: How militarisation facilitated collaborative but exclusive exchange in Sierra Leone's Ebola response
• Evaluation of potency and metabolic stability of diphyllin-derived Vacuolar-ATPase inhibitors
• Facility design and management. Strategies for high level biocontainment
• Factors associated with acceleration of clinical development for infectious diseases: a cross-sectional analysis of 10-year EMA registration data
• Feasibility Assessment of a Novel Isolation Care Tent In Uganda During the 2022 Sudan ebolavirus Outbreak
• Fully human monoclonal antibodies against Ebola virus possess complete protection in a hamster model
• Genome-wide CRISPR/Cas9 screen identifies SLC39A9 and PIK3C3 as crucial entry factors for Ebola virus infection
• Geographic information system and information visualization capacity building: Successful polio eradication and current and future challenges in the COVID-19 era for the World Health Organization's African region
• Global health diplomacy in humanitarian action
• Global Perspective on COVID-19 Therapies, Cardiovascular Outcomes, and Implications for Long COVID: A State-of-the-Art Review
• Health and non-health benefits and equity impacts of individual-level economic relief programs during epidemics/pandemics in high income settings: a scoping review
• Healthcare Providers' and Frontline Workers' Experiences of an Ebola Vaccine Trial in the Boende Health District of the Democratic Republic of the Congo
• Hepatitis C virus diversity and treatment outcomes in Benin: a prospective cohort study
• High seroreactivities to orthoebolaviruses in rural Cameroon: a case-control study on non-human primate bites and a cross-sectional survey in rural population
• Hippo signaling pathway regulates Ebola virus transcription and egress
• How does the polymerase of non-segmented negative strand RNA viruses commit to transcription or genome replication?
• Identification of Prospective Ebola Virus VP35 and VP40 Protein Inhibitors from Myxobacterial Natural Products
• Improved thermal stabilization of VSV-vector with enhanced vacuum drying in pullulan and trehalose-based films
• Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
• In silico exploration of deep-sea fungal metabolites as inhibitor of Ebola and Marburg VP35 and VP40
• Infection prevention and control studies for care of patients with suspected or confirmed filovirus disease in healthcare settings, with focus on Ebola and Marburg: an integrative review
• Innate and cellular immune response to the Ebola vaccine Ad26.ZEBOV, MVA-BN-Filo: an ancillary study of the EBL2001 phase II trial
• Invisible and undervalued: A qualitative study of laboratory workers' experiences and perceptions of laboratory strengthening in Sierra Leone
• Knowledge, attitudes, and practices and long-term immune response after rVSVdeltaG-ZEBOV-GP Ebola vaccination in healthcare workers in high-risk districts in Uganda
• Learning interventions and training methods in health emergencies: A scoping review
• Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping review
• Low-Input, High-Resolution 5' Terminal Filovirus RNA Sequencing with ViBE-Seq
• Macaque antibodies targeting Marburg virus glycoprotein induced by multivalent immunization
• Marburg virus exploits the Rab11-mediated endocytic pathway in viral-particle production
• Modeling approaches to inform travel-related policies for COVID-19 containment: a scoping review and future directions
• Modeling zoonotic and vector-borne viruses
• Multidisciplinary approaches to combat emerging viruses: diagnostics, therapeutic gene and vaccine delivery, and nanotherapeutics
• N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors
• National burden of Ebola virus disease in Democratic Republic of the Congo: the urgency to act
• Novel proteolytic activation of Ebolavirus glycoprotein GP by TMPRSS2 and cathepsin L at an uncharted position can compensate for furin cleavage
• On alert for Ebola: public health risk assessment of travellers from Uganda to the U.S. during the 2022 outbreak
• Optimizing the timing of an end-of-outbreak declaration: Ebola virus disease in the Democratic Republic of the Congo
• Physical and psychological status of emergency assistance personnel at major public health events: a qualitative descriptive study
• Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse
• Prevalence of human filovirus infections in sub-Saharan Africa: A systematic review and meta-analysis protocol
• Prevalence of somatic symptoms among Ebola Virus Disease (EVD) survivors in Africa: a systematic review and meta-analysis
• Prevention and control of Ebola virus transmission: mathematical modelling and data fitting
• Probing scaffold size effects on multivalent lectin-glycan binding affinity, thermodynamics and antiviral properties using polyvalent glycan-gold nanoparticles
• Psychological distress among healthcare professionals in Mbarara, following the 2022 Ebola Virus Disease outbreak in Uganda: a mixed methods study
• Public health emergency management capacity building in Guinea: 2014-2019
• Rapid detection of Ebolavirus using isothermal recombinase-aided amplification
• Readiness in preventing filovirus epidemics by use of the marketed vaccines against Zaire Ebola virus disease as prototypes
• Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-deltaG-ZEBOV-GP in a sub-Saharan African paediatric population: a randomised controlled, open-label trial in children aged 1-12 years living in Lambarene, Gabon
• Resilience of mental health services amidst Ebola disease outbreaks in Africa
• Sentiment Analysis of Social Media Data on Ebola Outbreak Using Deep Learning Classifiers
• Single domain antibodies from camelids in the treatment of microbial infections
• SpatialWavePredict: a tutorial-based primer and toolbox for forecasting growth trajectories using the ensemble spatial wave sub-epidemic modeling framework
• Spatiotemporal dynamics of epidemiology diseases: mobility based risk and short-term prediction modeling of COVID-19
• Strategies to foster community engagement for epidemic and pandemic preparedness and response in sub-Saharan Africa: a scoping review protocol
• Structure based screening and molecular docking with dynamic simulation of natural secondary metabolites to target RNA-dependent RNA polymerase of five different retroviruses
• The 2014 West Africa Ebola crisis: lessons from UK Defence Healthcare Engagement in Sierra Leone
• The complete pathway for co-transcriptional mRNA maturation within a large protein of a non-segmented negative-strand RNA virus
• The Ethical Obligation to Treat Infectious Patients: A Systematic Review of Reasons
• The Importance of Networks and Relationships: Leveraging the Biocontainment Unit Leadership Workgroup for Special Pathogen Outbreak Response
• Transport of Patients With High-Consequence Infectious Diseases: Development of European Capacity in Norway
• Understanding the delay in identifying Sudan Virus Disease: gaps in integrated disease surveillance and response and community-based surveillance to detect viral hemorrhagic fever outbreaks in Uganda, September 2022
• Using real-time modelling to inform the 2017 Ebola outbreak response in DR Congo
• Using structure prediction of negative sense RNA virus nucleoproteins to assess evolutionary relationships
• Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview